Shenzhen Juntesun Bioscience Co., Ltd.

Shenzhen Juntesun Bioscience Co., Ltd. is a clinical-stage biotechnology company based in Shenzhen, China, specializing in the development of growth factor-based therapies for regenerative medicine. The company's primary focus is on fibroblast growth factors (FGF) and their application in treating chronic and acute wounds, such as diabetic foot ulcers and severe burns. Their lead product candidate, JTS-01, is a recombinant protein formulation designed to promote tissue regeneration and accelerate the healing process. Juntesun Bioscience operates a comprehensive R&D and manufacturing infrastructure to advance its pipeline of biological wound care solutions. The company leverages deep academic ties to growth factor research to address significant unmet needs in dermatology and wound management.